Newsroom

Newsroom

NeoGenomics Set to Join Russell 3000 Index

Press Release
Read More

NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition

Press Release
Read More

NeoGenomics Announces Promotions

Press Release
Read More

Measurement of Immune Infiltration in ER, PR, HER2 IHC Subtypes Reveals Different Populations That May Benefit from Immunotherapy

Literature
Read More

MultiOmyx™: A multiplexed immunofluorescent assay capable of profiling protein expression and phosphorylation, in combination with next-generation sequencing from a single FFPE tissue section

Literature
Read More

NeoGenomics Schedules its Q1 2015 Earnings Release for April 28, 2015

Press Release
Read More

ALK positivity rate is highly dependent on patient age

Literature
Read More

Genetic array analysis of follicular dendritic cell carcinoma

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients